GLP- 1 Receptor Agonists in Combination with Insulin The GLP- 1 receptor agonists have been shown to improve blood glucose control when used in conjunction with insulin, particularly basal insulin, and may be particularly useful in the treatment of advanced T2DM [108]
An Evidence-Based Perspective Key Points GLP-1 medications are safe from a psychiatric perspective and dont increase risk of depression or suicidality These medications improve mental health-related quality of life and eating behaviors beyond their effects on weight Lower doses combined with comprehensive psychological and lifestyle support produce excellent results with minimal side effects GLP-1s reduce inflammation, which directly benefits mood and neurotransmitter function Psychiatrists are well-positioned to prescribe GLP-1s as part of integrated metabolic-psychiatric care I want to address a question that comes up constantly in psychiatric circles right now
MEDVis approach reflects this evolution, offering a pathway that balances accessibility with clinical rigor
Cagrilintides Lau phase 2 trial is the cleaner look at the amylin compound alone, since most of its public profile comes wrapped in CagriSema data
Practical Strategies to Stay Warm on Wegovy Managing the chills requires a combination of external adjustments and internal support
Efectos secundarios Cmo minimizarlos Comienza con dosis bajas y escala gradualmente